SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 214 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $89,729,776 | +40.5% | 101,275,142 | +149.0% | 0.00% | -25.0% |
| Q3 2022 | $63,851,000 | -19.9% | 40,669,276 | +2.5% | 0.00% | -20.0% |
| Q2 2022 | $79,719,000 | +0.7% | 39,661,099 | +16.8% | 0.01% | +25.0% |
| Q1 2022 | $79,129,000 | +16.6% | 33,960,884 | +132.7% | 0.00% | +33.3% |
| Q4 2021 | $67,870,000 | -27.6% | 14,595,754 | +18.8% | 0.00% | -40.0% |
| Q3 2021 | $93,753,000 | -5.4% | 12,287,375 | +20.1% | 0.01% | 0.0% |
| Q2 2021 | $99,153,000 | +22.5% | 10,232,527 | +4.6% | 0.01% | 0.0% |
| Q1 2021 | $80,937,000 | -6.4% | 9,786,760 | -22.8% | 0.01% | 0.0% |
| Q4 2020 | $86,508,000 | -33.7% | 12,675,183 | +8.3% | 0.01% | -44.4% |
| Q3 2020 | $130,551,000 | +108.1% | 11,708,587 | +17.2% | 0.01% | +80.0% |
| Q2 2020 | $62,740,000 | +1381.5% | 9,990,515 | +334.1% | 0.01% | – |
| Q1 2020 | $4,235,000 | -45.2% | 2,301,587 | +0.6% | 0.00% | -100.0% |
| Q4 2019 | $7,730,000 | +58.8% | 2,286,913 | +0.5% | 0.00% | – |
| Q3 2019 | $4,868,000 | -19.8% | 2,274,705 | +0.0% | 0.00% | – |
| Q2 2019 | $6,072,000 | -39.6% | 2,274,194 | +7.4% | 0.00% | -100.0% |
| Q1 2019 | $10,057,000 | -30.7% | 2,117,328 | -65.0% | 0.00% | 0.0% |
| Q4 2018 | $14,522,000 | -52.6% | 6,050,798 | -13.0% | 0.00% | -50.0% |
| Q3 2018 | $30,611,000 | -41.2% | 6,957,785 | -3.8% | 0.00% | -50.0% |
| Q2 2018 | $52,067,000 | +96.0% | 7,232,063 | +40.2% | 0.00% | +100.0% |
| Q1 2018 | $26,566,000 | +33527.8% | 5,158,346 | +24526.9% | 0.00% | – |
| Q4 2017 | $79,000 | +229.2% | 20,946 | +52.9% | 0.00% | – |
| Q3 2017 | $24,000 | -11.1% | 13,700 | 0.0% | 0.00% | – |
| Q2 2017 | $27,000 | -98.7% | 13,700 | -97.3% | 0.00% | – |
| Q1 2017 | $2,029,000 | -19.5% | 513,168 | -0.3% | 0.00% | – |
| Q4 2016 | $2,519,000 | -32.9% | 514,597 | +6.0% | 0.00% | – |
| Q3 2016 | $3,756,000 | +39.4% | 485,521 | +0.9% | 0.00% | – |
| Q2 2016 | $2,694,000 | +2.0% | 481,317 | -2.0% | 0.00% | – |
| Q1 2016 | $2,642,000 | -30.5% | 491,085 | +12.5% | 0.00% | – |
| Q4 2015 | $3,799,000 | +6.6% | 436,525 | +2.8% | 0.00% | – |
| Q3 2015 | $3,564,000 | -31.1% | 424,752 | +44.8% | 0.00% | -100.0% |
| Q2 2015 | $5,171,000 | +3541.5% | 293,275 | +2284.3% | 0.00% | – |
| Q1 2015 | $142,000 | +10.9% | 12,300 | -3.1% | 0.00% | – |
| Q4 2014 | $128,000 | +172.3% | 12,700 | +21.0% | 0.00% | – |
| Q3 2014 | $47,000 | -33.8% | 10,500 | 0.0% | 0.00% | – |
| Q2 2014 | $71,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |